HUE063812T2 - Sejttenyésztési eljárások - Google Patents

Sejttenyésztési eljárások

Info

Publication number
HUE063812T2
HUE063812T2 HUE18811257A HUE18811257A HUE063812T2 HU E063812 T2 HUE063812 T2 HU E063812T2 HU E18811257 A HUE18811257 A HU E18811257A HU E18811257 A HUE18811257 A HU E18811257A HU E063812 T2 HUE063812 T2 HU E063812T2
Authority
HU
Hungary
Prior art keywords
cell culture
culture methods
methods
cell
culture
Prior art date
Application number
HUE18811257A
Other languages
English (en)
Hungarian (hu)
Inventor
Valentine Chevallier
Nadine Kochanowski
Laetitia Malphettes
Vincent Adolphe Carol Cool
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60629439&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE063812(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Publication of HUE063812T2 publication Critical patent/HUE063812T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515—Complete light chain, i.e. VL + CL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
HUE18811257A 2017-12-01 2018-11-29 Sejttenyésztési eljárások HUE063812T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17204978.5A EP3492582A1 (en) 2017-12-01 2017-12-01 Cell culture methods

Publications (1)

Publication Number Publication Date
HUE063812T2 true HUE063812T2 (hu) 2024-02-28

Family

ID=60629439

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18811257A HUE063812T2 (hu) 2017-12-01 2018-11-29 Sejttenyésztési eljárások

Country Status (14)

Country Link
US (1) US11859203B2 (cg-RX-API-DMAC10.html)
EP (2) EP3492582A1 (cg-RX-API-DMAC10.html)
JP (1) JP7422072B2 (cg-RX-API-DMAC10.html)
KR (1) KR20200092348A (cg-RX-API-DMAC10.html)
CN (1) CN111417715B (cg-RX-API-DMAC10.html)
BR (1) BR112020010473A2 (cg-RX-API-DMAC10.html)
CA (1) CA3083680A1 (cg-RX-API-DMAC10.html)
EA (1) EA202091349A1 (cg-RX-API-DMAC10.html)
ES (1) ES2963653T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20231175T1 (cg-RX-API-DMAC10.html)
HU (1) HUE063812T2 (cg-RX-API-DMAC10.html)
PL (1) PL3717631T3 (cg-RX-API-DMAC10.html)
SG (1) SG11202004935UA (cg-RX-API-DMAC10.html)
WO (1) WO2019106091A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods
CN112391350A (zh) * 2020-10-30 2021-02-23 北京双鹭药业股份有限公司 高效表达抗egfr单克隆抗体细胞的筛选培养方法
GB202105424D0 (en) 2021-04-16 2021-06-02 UCB Biopharma SRL Cell culture processes
EP4166651A1 (en) 2021-10-18 2023-04-19 Evonik Operations GmbH Methods and composition to increase cellular glutathione level
WO2023067626A1 (en) * 2021-10-20 2023-04-27 Dr. Reddy's Laboratories Limited A cell culture process to produce an antibody composition
US20250163487A1 (en) * 2022-02-21 2025-05-22 Chugai Seiyaku Kabushiki Kaisha Perfusion culture method
WO2024024720A1 (ja) * 2022-07-25 2024-02-01 味の素株式会社 細胞培養用の培地

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
EP2221361A3 (en) 1996-08-30 2011-02-09 Life Technologies Corporation Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
KR20010075000A (ko) * 1998-10-09 2001-08-09 에가시라 구니오 시스테인 유도체
KR20050070512A (ko) 2003-12-30 2005-07-07 삼성정밀화학 주식회사 재조합 단백질의 생산성을 증가시키는 무혈청 배지 및동물세포 배양방법
EP2500416A1 (en) 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
TW201516149A (zh) * 2006-09-13 2015-05-01 Abbvie Inc 細胞培養改良
LT2563906T (lt) 2010-04-26 2018-02-26 Novartis Ag Cho ląstelių kultivavimo būdas
WO2013158275A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Cell culture methods to reduce acidic species
US20130281355A1 (en) 2012-04-24 2013-10-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
BR112016027797A2 (pt) 2014-06-18 2017-10-31 Medimmune Llc métodos e meios de cultura de células compreendendo n-acetilcisteína
SG11201809408SA (en) * 2016-04-28 2018-11-29 Merck Patent Gmbh Method for reducing the trisulfide level in proteins
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods

Also Published As

Publication number Publication date
EA202091349A1 (ru) 2020-08-20
KR20200092348A (ko) 2020-08-03
US11859203B2 (en) 2024-01-02
CN111417715B (zh) 2024-08-27
ES2963653T3 (es) 2024-04-01
SG11202004935UA (en) 2020-06-29
EP3717631B1 (en) 2023-08-30
WO2019106091A1 (en) 2019-06-06
JP2021503938A (ja) 2021-02-15
EP3717631A1 (en) 2020-10-07
JP7422072B2 (ja) 2024-01-25
EP3492582A1 (en) 2019-06-05
CN111417715A (zh) 2020-07-14
US20200308536A1 (en) 2020-10-01
CA3083680A1 (en) 2019-06-06
BR112020010473A2 (pt) 2020-11-24
EP3717631C0 (en) 2023-08-30
PL3717631T3 (pl) 2024-03-04
HRP20231175T1 (hr) 2024-01-19

Similar Documents

Publication Publication Date Title
GB201611982D0 (en) Cell culture
SG11201703493SA (en) Cell culture insert
SG10202005898PA (en) Cell culture medium
PL3652291T3 (pl) Naczynie do hodowli komórkowej
SG11201800694QA (en) Cell culture container
GB201509202D0 (en) Semi-static cell culture
SG11201609916RA (en) Culture method and cell mass
GB201712733D0 (en) Methods & cells
SG11201706090SA (en) Cell culturing method and kit
LT3766582T (lt) Ląstelių kultūra
IL261999A (en) Cell culture process
SG11202004935UA (en) Cell culture methods
GB201715930D0 (en) Cell Culture Medium
SG11202005559VA (en) Improved cell culture device
PL3287521T3 (pl) Hodowla komórkowa
PL3630946T3 (pl) Sposoby hodowli komórkowych
GB201608764D0 (en) Novel cell culture
SG11201800503YA (en) Stem cell culturing method
EP3260528A4 (en) Cell culture apparatus
GB201715518D0 (en) Cell cultivation methods
SG10202010002RA (en) Cell culture
GB201711892D0 (en) Improved culture methods
TWI563082B (en) Cell culture device
GB201608847D0 (en) Improved Cell Culture using beads
GB201421342D0 (en) Cell culture